Real-time software company Vection Technologies Ltd (ASX:VR1) has lodged a provisional patent application covering, among others, technology used in the company’s Augmented Reality (AR) healthcare solutions.
The provisional application, named “Method for customisation and re-execution of video sequences in a virtual world” (VR-Replay), was filed with the Italian Patent and Trademark Office (UIBM) and, if granted, will allow subsequent patents to be granted in the EU.
Managing Director, Gianmarco Biagi, said the company intends to eventually seek patent protection in additional major jurisdictions including Australia and the USA.
The lodgement of the VR-Replay patent application represents a key initiative to position the Company in an increasingly strategic position to pursue its healthcare strategy. This announcement follows on from the commencement of a trial with the AORN S.G. Moscati hospital and LUISS Business School, to also introduce AR solutions in the Italian Model for Risk Management in Healthcare promoted by LUISS Business School, a national model that operators must adopt to manage risk in Healthcare. (ASX:21 September 2020)
Mr Biagi said the VR-Replay patent application relates to a proprietary technology for structured recording in virtual reality, capable of synthesising digital video to be viewed across any 3D viewing device and edited through suitable software.
In the healthcare domain, this technology enables multiple functionalities, including the superimposition of biometric data, sourced from electronic medical records, in the medical professional’s field of view via wearable devices.
The lodgement of this patent application represents an additional step forward in the company’s overarching strategy and, if granted, will enable the company to protect its interests within the Healthcare market segment, while progressing with its first hospital trial and the introduction of augmented reality as a new standard in healthcare risk management,” Mr Biagi said.
“Vection Technologies’ management remain committed to the pursuit of growth, aligned with the Company’s long-term strategy, towards value creation for all stakeholders.”